Paid Clinical Trials and Focus Groups by Location |
|
|
|
Condition: Peripheral Arterial Occlusive Disease
Intervention:
Sponsors: Heart Center Bad Krozingen; Johann Wolfgang Goethe University Hospitals
Enrolling by invitation - verified March 2010
Conditions: Cystic Fibrosis; Rhinosinusitis
Interventions: Drug: NaCl 6%; Drug: NaCl 0,9%
Sponsor: University of Jena
Not yet recruiting - verified March 2010
Condition: ST Segment Elevation Acute Coronary Syndrome
Interventions: Drug: Bivalirudin; Drug: Heparin
Sponsor: The Medicines Company
Recruiting - verified March 2010
Condition: Epilepsy
Intervention:
Sponsor: Desitin Arzneimittel GmbH
Recruiting - verified March 2010
Condition: Crohn´s Disease
Interventions: Drug: budesonide; Drug: budesonide
Sponsor: Dr. Falk Pharma GmbH
Recruiting - verified March 2010
Condition: Atrophic Vaginitis
Interventions: Drug: intravaginal estradiol; Drug: intravaginal estradiol
Sponsor: Novo Nordisk
Not yet recruiting - verified March 2010
Conditions: Cystocele; Uterine Prolapse
Intervention: Device: TiLOOP® Total 6 (Surgical mesh implantation)
Sponsors: pfm Produkte fuer die Medizin AG; Aix Scientifics; GfE Medizintechnik GmbH
Not yet recruiting - verified March 2010
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIBW 2992; Drug: Investigator´s choice of chemotherapy
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: NOX-E36; Drug: NOX-E36
Sponsors: Noxxon Pharma AG; Profil Institut für Stoffwechselforschung GmbH
Not yet recruiting - verified March 2010
Condition: Coronary De-novo Stenoses
Interventions: Device: SeQuent®Please (Paclitaxel coated balloon); Device: Taxus™Liberté™ (Paclitaxel eluting stent)
Sponsors: University Hospital, Saarland; B. Braun Melsungen AG
Not yet recruiting - verified March 2010
Condition: Surgical Wound Dehiscence
Interventions: Device: Strattice(TM) Reconstructive Tissue Matrix; Procedure: Suture/suture with absorbable mesh
Sponsor: LifeCell
Not yet recruiting - verified March 2010
Condition: Stroke
Intervention:
Sponsor: Charite University, Berlin, Germany
Recruiting - verified March 2010
Conditions: Macular Pucker; Macular Hole; Vitreoretinal Surgery
Interventions: Procedure: Indocyanine green; Procedure: Brilliant blue arm
Sponsor: University of Cologne
Recruiting - verified October 2007
Condition: Intracranial Aneurysms
Interventions: Device: Endovascular treatment of intracranial aneurysms; Device: Endovascular treatment of intracranial aneurysm with coils
Sponsor: Balt International
Recruiting - verified March 2010
Condition: Contraception
Interventions: Drug: Gestodene/EE Patch (BAY86-5016); Drug: Gestodene/EE Patch (BAY86-5016); Drug: Gestodene/EE Patch (BAY86-5016)
Sponsor: Bayer
Recruiting - verified March 2010
Conditions: Epimacular Gliosis; Macular Hole
Intervention:
Sponsor: University Hospital Tuebingen
Recruiting - verified March 2010
Conditions: Advanced Gastric Cancer; Gastro-esophageal Junction Cancer
Interventions: Drug: AUY922; Drug: Docetaxel or Irinotecan
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified March 2010
Condition: Postoperative Pain
Interventions: Drug: Morphine 6-glucuronide; Drug: Morphine
Sponsors: Paion UK Ltd.; Chiltern International Ltd.; HFL Ltd.
Completed - verified March 2010
Condition: Peripheral Artery Disease
Intervention: Procedure: Percutaneous transluminal angioplasty (PTA)
Sponsors: University Hospital, Saarland; InnoRa GmbH
Not yet recruiting - verified March 2010
Conditions: Allergic Rhinoconjunctivitis; Chronic Urticaria
Intervention: Drug: Bilastine
Sponsor: Faes Farma, S.A.
Recruiting - verified March 2010
Condition: Hypertrophic Cardiomyopathy
Intervention: Procedure: additional temporary pacewire
Sponsor: Johann Wolfgang Goethe University Hospitals
Not yet recruiting - verified March 2010
Condition: Wound Infection
Interventions: Drug: Daptomycin; Drug: Cefuroxime
Sponsors: Hannover Medical School; Novartis
Recruiting - verified March 2010
Condition: Schizophrenia
Intervention: Behavioral: Assertive Community Treatment (ACT)
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Completed - verified March 2010
Condition: Mild to Moderate Atopic Dermatitis
Interventions: Device: Atopiclair; Device: EHK02-01
Sponsor: Bitop AG
Recruiting - verified March 2010
Condition: Myelodysplastic Syndromes
Intervention: Drug: Lenalidomide
Sponsors: Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH; ClinAssess - Gesellschaft für klinische Forschung mbH
Recruiting - verified March 2010
Condition: Haematological Malignancies
Interventions: Drug: AS703569; Drug: AS703569
Sponsor: EMD Serono
Active, not recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: insulin glargine; Drug: NN1250; Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Healthy Volunteers
Intervention: Other: needle stimulation
Sponsors: Charite University, Berlin, Germany; Max Planck Institute for Human Cognitive and Brain Sciences; Institute for Social Medicine, Epidemiology, and Health Economics, Charité
Recruiting - verified February 2010
Condition: Ischemic Stroke
Intervention:
Sponsor: Charite University, Berlin, Germany
Recruiting - verified March 2010
Condition: Ankylosing Spondylitis
Intervention: Drug: adalimumab (Humira)
Sponsor: Abbott
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium and Formoterol; Drug: Placebo; Drug: Formoterol; Drug: Aclidinium; Drug: Aclidinium and Formoterol
Sponsors: Almirall, S.A.; Forest Laboratories
Recruiting - verified March 2010
Condition: Alzheimer Disease
Interventions: Drug: Acitretin; Drug: Placebo
Sponsors: Johannes Gutenberg University Mainz; Alzheimer Forschungsinitiative e.V. (AFI)
Not yet recruiting - verified January 2010
Conditions: Diabetes Mellitus 1 or 2; Midfoot Charcot Neuroarthropathy
Interventions: Procedure: Surgery with Midfoot Fusion Bolt; Procedure: Cast treatment
Sponsor: AO Clinical Investigation and Documentation
Not yet recruiting - verified March 2010
Condition: Acute-on-chronic Liver Failure
Interventions: Device: Hepa Wash; Procedure: Standard Medical Therapy
Sponsor: Hepa Wash GmbH
Not yet recruiting - verified March 2010
Condition: Hepatic Dysfunction in Critically Ill Patients
Interventions: Device: Hepa Wash; Procedure: Standard Medical Therapy
Sponsor: Hepa Wash GmbH
Not yet recruiting - verified March 2010
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
Sponsor: Abbott
Active, not recruiting - verified March 2010
Condition: Crohn´s Disease
Intervention: Biological: adalimumab (Humira)
Sponsor: Abbott
Recruiting - verified March 2010
Condition: Ovarian Cancer
Interventions: Drug: olaparib; Drug: paclitaxel; Drug: carboplatin
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
Sponsor: Abbott
Active, not recruiting - verified March 2010
Condition: Peripheral Vascular Disease
Interventions: Device: PTA; Device: PTA with PEB; Procedure: Percutaneous Transluminal Angioplasty (PTA)
Sponsor: Deutsches Herzzentrum Muenchen
Not yet recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsor: Abbott
Recruiting - verified February 2010
Condition: Patients Who Participated in an Intravitreal Brimo PS DDS® Study
Intervention: Drug: intravitreal brimonidine tartrate implant using Posterior Segment Drug Delivery System (PS DDS®) Applicator
Sponsor: Allergan
Recruiting - verified February 2010
Conditions: Renal Insufficiency; Secondary Hyperparathyroidism
Intervention: Drug: Zemplar (paricalcitol)
Sponsor: Abbott
Recruiting - verified March 2010
Condition: Hormone Withdrawal Associated Symptoms
Interventions: Drug: EE20/DRSP (YAZ, BAY86-5300); Drug: Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)
Sponsor: Bayer
Not yet recruiting - verified February 2010
Condition: Moderate to Severe Plaque Psoriasis
Intervention: Biological: adalimumab (Humira)
Sponsor: Abbott
Recruiting - verified February 2010
Condition: Arthritis, Psoriatic
Interventions: Drug: ustekinumab; Drug: placebo; Drug: placebo; Drug: ustekinumab; Drug: ustekinumab; Drug: placebo; Drug: ustekinumab; Drug: ustekinumab
Sponsor: Centocor, Inc.
Not yet recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsor: Abbott
Recruiting - verified February 2010
Condition: Prostatic Neoplasms
Intervention:
Sponsor: Sanofi-Aventis
Recruiting - verified February 2010
Conditions: Cardiac Arrest; Hypothermia
Intervention:
Sponsor: University of Leipzig
Recruiting - verified January 2010
Condition: Thoracotomy
Interventions: Procedure: epidural anesthesia; Procedure: intercostal anesthesia
Sponsor: University of Ulm
Completed - verified February 2010
Condition: Pancreatic Adenocarcinoma
Interventions: Device: Gemcitabine + regional hyperthermia; Drug: Gemcitabine
Sponsors: Klinikum der Universitaet Muenchen, Grosshadern; European Society for Hyperthermic Oncology; Institute for Medical Informatics, Biometry and Epidemiology, Munich; ClinAssess GmbH, Leverkusen, Germany
Not yet recruiting - verified March 2010
Condition: Human Immunodeficiency Virus
Intervention: Drug: lopinavir/ritonavir (Kaletra)
Sponsor: Abbott
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsor: Abbott
Recruiting - verified February 2010
Conditions: Arrhythmia; Heart Failure
Intervention:
Sponsor: Medtronic Cardiac Rhythm Disease Management
Recruiting - verified February 2010
Conditions: Arrhythmia; Heart Failure
Intervention:
Sponsor: Medtronic Cardiac Rhythm Disease Management
Recruiting - verified February 2010
Condition: Arthritis, Rheumatoid
Intervention: Drug: Prednisone
Sponsor: Merck KGaA
Recruiting - verified February 2010
Conditions: Arrhythmia; Bradycardia
Intervention:
Sponsor: Medtronic Cardiac Rhythm Disease Management
Recruiting - verified February 2010
Condition: Severe Aortic Valve Stenosis
Intervention: Device: Medtronic CoreValve System
Sponsor: Medtronic Bakken Research Center
Recruiting - verified March 2010
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
Sponsor: Abbott
Active, not recruiting - verified February 2010
Condition: Severe Respiratory Syncytial Virus Infection
Intervention:
Sponsor: Abbott
Completed - verified February 2010
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
Sponsor: Abbott
Active, not recruiting - verified March 2010
Condition: Atelectasis
Interventions: Other: Spontaneous Breathing; Other: Pressure Controlled Ventilation; Other: Pressure Support Ventilation
Sponsor: Dresden University of Technology
Not yet recruiting - verified February 2010
Conditions: Ascites; Hepatectomy
Interventions: Procedure: Portal venous pressure; Procedure: Portal venous flow; Procedure: Hepatic artery flow
Sponsor: University of Heidelberg
Enrolling by invitation - verified February 2010
Conditions: Hepatic Metastases; Colorectal Cancer
Intervention: Procedure: Routine hilar lymphadenectomy
Sponsor: University of Heidelberg
Enrolling by invitation - verified February 2010
Condition: HCV Infection
Interventions: Drug: GS-9256; Drug: GS-9190; Drug: Ribavirin
Sponsor: Gilead Sciences
Recruiting - verified March 2010
Condition: Healthy Volunteers
Interventions: Drug: Dapagliflozin; Drug: Dapagliflozin
Sponsors: AstraZeneca; Bristol-Myers Squibb
Recruiting - verified February 2010
Condition: Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons
Interventions: Other: questionnaires; Biological: blood sampling; Other: clinical evaluation; Other: Dermatology evaluation; Other: Bone evaluation
Sponsor: University Hospital, Ghent
Recruiting - verified February 2010
Condition: Glioblastoma Multiforme
Interventions: Drug: APG101; Procedure: Blood drawing
Sponsor: Apogenix GmbH
Recruiting - verified March 2010
Condition: Schizophrenia
Intervention: Drug: Quetiapine XR
Sponsors: Hannover Medical School; Hannover Clinical Trial Center GmbH; AstraZeneca
Recruiting - verified February 2010
Condition: Peripheral Artery Disease
Intervention: Device: FlexStent Femoropopliteal Self-Expanding Stent System
Sponsor: Provascular GmbH
Recruiting - verified February 2010
Condition: Alcohol Dependence
Interventions: Drug: Varenicline; Drug: Placebo
Sponsors: Johannes Gutenberg University Mainz; Pfizer
Not yet recruiting - verified December 2009
Condition: ENT Surgery
Interventions: Device: Intermittent pneumatic compression (IPC); Device: IPC - placebo
Sponsors: University Hospital, Bonn; Masimo Corp. (loan of medical devices); Villa Sana GmbH (loan of medical devices)
Completed - verified January 2010
Condition: Food Allergy
Intervention:
Sponsor: University of Erlangen-Nürnberg Medical School
Not yet recruiting - verified February 2010
Conditions: Hypoxemia; Complications
Interventions: Procedure: Capnography; Procedure: Standard monitoring
Sponsor: Technische Universität München
Recruiting - verified February 2010
Conditions: Follicular Lymphoma; Mantle Cell Lymphoma
Intervention: Drug: Temsirolimus, Rituximab, Bendamustin
Sponsors: Johannes Gutenberg University Mainz; Wyeth; Mundipharma K.K.
Recruiting - verified November 2009
Condition: Severe Active Rheumatoid Arthritis According to the Current SPC
Intervention:
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Low Back Pain
Interventions: Other: educational booklet; Other: IRENA; Other: RÜCKGEWINN
Sponsors: University of Erlangen-Nürnberg Medical School; German Federal Pension Fund
Recruiting - verified February 2010
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: natalizumab; Drug: interferon beta 1-a; Drug: methylprednisolone; Other: IV placebo; Drug: glatiramer acetate
Sponsors: Biogen Idec; Elan Pharmaceuticals
Not yet recruiting - verified February 2010
Conditions: Hypoxemia; Complications
Intervention: Procedure: Capnography
Sponsor: Technische Universität München
Recruiting - verified February 2010
Condition: Lipid Metabolism Disorder
Intervention:
Sponsor: Merck
Recruiting - verified February 2010
Condition: Diarrhea
Interventions: Procedure: Colonoscopy; Procedure: Confocal Laser Endomicroscopy
Sponsor: University of Erlangen-Nürnberg Medical School
Recruiting - verified February 2010
Condition: Myopia
Interventions: Device: Focus DAILIES toric contact lens; Device: Biomedics Toric contact lens
Sponsor: Novartis
Recruiting - verified February 2010
Condition: Obesity
Interventions: Behavioral: "Ene mene fit - Eltern machen mit!"; Behavioral: Standard physical activity lessons
Sponsor: University of Heidelberg
Active, not recruiting - verified February 2010
Condition: Type 2 Diabetes
Intervention: Dietary Supplement: Isomaltulose
Sponsors: University of Giessen; Numico Research
Completed - verified November 2002
Condition: Glaucoma
Intervention: Device: HFA, Octopus, MATRIX
Sponsors: University Hospital Tuebingen; Pfizer
Recruiting - verified November 2008
Condition: Stroke
Intervention: Other: No intervention in this study
Sponsor: Johannes Gutenberg University Mainz
Recruiting - verified August 2008
Conditions: Acute Brain Injuries; TBI (Traumatic Brain Injury); Intracranial Hemorrhages
Intervention: Other: There are no interventions in this study
Sponsor: Johannes Gutenberg University Mainz
Completed - verified March 2001
Condition: Rheumatoid Arthritis
Intervention:
Sponsor: UCB, Inc.
Enrolling by invitation - verified March 2010
Condition: Intra-abdominal Infection
Interventions: Drug: Moxifloxacin (Avelox, BAY12-8039); Drug: Ertapenem, Amoxicillin/clavulanate
Sponsor: Bayer
Not yet recruiting - verified March 2010
Condition: Immunocompromised
Intervention: Biological: Focetria (2x H1N1 vaccine with MF59 adjuvants)
Sponsor: Competence Network Viral Hepatitis
Recruiting - verified February 2010
All Locations ... Germany 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
